Project Syndicate op-ed: Insulin Belongs to the World
In an op-ed published by Project Syndicate, Access to Medicine Foundation CEO Jayasree K. Iyer argues that governments and pharmaceutical companies must do their part to increase access to insulin in low- and middle-income countries – including not just older forms of human insulin, but also the innovative analog insulins which are increasingly becoming the preferred choice of both diabetes patients and doctors.
Foundation to deepen its work moving pharma companies on access to diabetes care
Each year, more than 100,000 children and young adults are diagnosed with type 1 diabetes. Although the products that can keep them alive do exist, these are often out of reach for people living in low- and middle-income countries. In 2022, the Foundation will assess the best solutions for pharma companies to build sustainable and equitable access to diabetes care.
What’s the use of anti-HIV injections when those who need it most can’t use it?
In an article for the Mail & Guardian, Yogan Pillay, Francois Venter and Fatima Hassan examine access to the HIV pre-exposure prohpylaxis (PrEP) drug CAB-LA in Sub-Saharan Africa, drawing on results from the Foundation's 2021 Access to Medicine Index.